Literature DB >> 23512205

Oligometastases: the new paradigm and options for radiotherapy. A critical review.

H Badakhshi1, A Grün, C Stromberger, V Budach, D Boehmer.   

Abstract

Traditional oncology distinguishes between two separate and incommensurable states in the evolution of solid malignancies: the localized disease, which is curable; and the disseminated status, which is per se palliative. Recently, a huge body of evidence suggests a fundamental change in the understanding of cancer, indicating an intermediate state in the trajectory of solid malignancies: the oligometastatic state. The following review will critically analyse existing hypotheses and facts from the basic sciences and try to contextualize it in regard to the clinical evidence available to date. Consecutively, it will try to draw possible clinical consequences for application of radiotherapy in this specific clinical scenario.

Entities:  

Mesh:

Year:  2013        PMID: 23512205     DOI: 10.1007/s00066-013-0326-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  59 in total

1.  Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis.

Authors:  Samuel Ryu; Fang Fang Yin; Jack Rock; Jingeng Zhu; Archie Chu; Eduard Kagan; Lisa Rogers; Munther Ajlouni; Mark Rosenblum; Jae Ho Kim
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

2.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

3.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

Review 4.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 5.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 6.  Karnofsky Memorial Lecture. Natural history of small breast cancers.

Authors:  S Hellman
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544

7.  Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results.

Authors:  Giovanni Ambrosino; Francesco Polistina; Giorgio Costantin; Paolo Francescon; Rosabianca Guglielmi; Pierluigi Zanco; Franco Casamassima; Antonio Febbraro; Giorgio Gerunda; Franco Lumachi
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

8.  Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis.

Authors:  D Rades; J D Kueter; J Gliemroth; T Veninga; A Pluemer; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-01-12       Impact factor: 3.621

9.  A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.

Authors:  Ingrid Fumagalli; Jean-Emmanuel Bibault; Sylvain Dewas; Andrew Kramar; Xavier Mirabel; Bernard Prevost; Thomas Lacornerie; Hajer Jerraya; Eric Lartigau
Journal:  Radiat Oncol       Date:  2012-09-27       Impact factor: 3.481

10.  Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation.

Authors:  Carmen Chak-Lui Wong; Daniele M Gilkes; Huafeng Zhang; Jasper Chen; Hong Wei; Pallavi Chaturvedi; Stephanie I Fraley; Chun-Ming Wong; Ui-Soon Khoo; Irene Oi-Lin Ng; Denis Wirtz; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

View more
  7 in total

1.  Palliative radiotherapy for thoracic spine metastases: Dosimetric advantage of three-dimensional conformal plans.

Authors:  Seung-Gu Yeo
Journal:  Oncol Lett       Date:  2015-05-13       Impact factor: 2.967

2.  Impact of comorbidity on survival after palliative radiotherapy.

Authors:  Carsten Nieder; Kirsten Engljähringer; Kent Angelo
Journal:  Strahlenther Onkol       Date:  2014-07-15       Impact factor: 3.621

3.  Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases.

Authors:  Frederick Mantel; Stefan Glatz; André Toussaint; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-06-27       Impact factor: 3.621

Review 4.  Radiotherapy for SMAD4-negative musculoskeletal lesions from pancreatic cancer: case report and review.

Authors:  Constantinos Zamboglou; Peter Bronsert; Simon Küsters; Natalie Salm; Marc Azèmar; Thomas Brunner
Journal:  Strahlenther Onkol       Date:  2014-10-10       Impact factor: 3.621

5.  Is elective inguinal radiotherapy necessary for locally advanced rectal adenocarcinoma invading anal canal?

Authors:  Seung-Gu Yeo; Hyeon Woo Lim; Dae Yong Kim; Tae Hyun Kim; Sun Young Kim; Ji Yeon Baek; Hee Jin Chang; Ji Won Park; Jae Hwan Oh
Journal:  Radiat Oncol       Date:  2014-12-23       Impact factor: 3.481

6.  Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.

Authors:  Wen Ouyang; Jing Yu; Shuake Nuerjiang; Zhijun Li; Dajiang Wang; Xiaoyong Wang; Junhong Zhang; Conghua Xie
Journal:  Cancer Med       Date:  2019-06-27       Impact factor: 4.452

Review 7.  Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization).

Authors:  Peter Hass; Konrad Mohnike
Journal:  Viszeralmedizin       Date:  2014-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.